Showing results (1421-1430 of 1,479) with videos related to

Sort By:
Pageof 148
The Lancet. Oncology|May 7, 2025
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trialAlexandra Gilbert, Richard Adams, Joanne Webster, et al.
Nature Communications|October 29, 2023
Impact of COVID-19 on mortality in coastal Kenya: a longitudinal open cohort studyM Otiende, A Nyaguara, C Bottomley, et al.
The Lancet. Global Health|February 20, 2018
Comparative efficacy of low-dose versus standard-dose azithromycin for patients with yaws: a randomised non-inferiority trial in Ghana and Papua New GuineaMichael Marks, Oriol Mitjà, Christian Bottomley, et al.
European Urology|July 15, 2017
Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer TrialChristopher C Parker, Robert E Coleman, Oliver Sartor, et al.
Nature Biotechnology|May 1, 2007
Genome sequence and identification of candidate vaccine antigens from the animal pathogen Dichelobacter nodosusGarry S A Myers, Dane Parker, Keith Al-Hasani, et al.
Journal of Global Health|June 9, 2020
Impact of routine vaccination against Haemophilus influenzae type b in The Gambia: 20 years after its introductionSyed Ma Zaman, Stephen Rc Howie, Magnus Ochoge, et al.
The Lancet. Oncology|September 8, 2018
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic reviewMadeline Pe, Lien Dorme, Corneel Coens, et al.
Cell|November 12, 2013
KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidationLaura R Pearce, Neli Atanassova, Matthew C Banton, et al.
The New England Journal of Medicine|July 19, 2013
Alpha emitter radium-223 and survival in metastatic prostate cancerC Parker, S Nilsson, D Heinrich, et al.
Human Mutation|July 23, 2021
SLC25A38 congenital sideroblastic anemia: Phenotypes and genotypes of 31 individuals from 24 families, including 11 novel mutations, and a review of the literatureMatthew M Heeney, Simon Berhe, Dean R Campagna, et al.
Pageof 148